美国血液技术 HAE 深 沪
等待开盘 08-27 09:30:00 美东时间
106.60
-1.720
-1.59%
华盛通- 最 高108.08
- 今 开107.75
- 成交量 66.13万股
- 最 低 106.42
- 昨 收 108.32
- 总市值 48.50亿
- 52周最高 109.5707
- 市盈率 静 51.88
- 换手率 1.45%
- 52周最低 47.315
- 委 比 0.00%
- 总股本 4549.71万
- 历史最高 142.11
- 量 比 0.81
- 振 幅 1.53%
- 历史最低 25.98
- 每 手 1
- 风险率 13.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 罗斯百货、迪尔股份获多家大行上调目标价；沃尔玛、Advance遭多家大行下调目标价
今日重点评级关注：摩根士丹利：维持Ultragenyx Pharmaceutical"超配"评级，目标价从67美元升至74美元；Truist Securities：维持Solid Biosciences"买入"评级，目标价从16美元升至20美元
08-24 16:40
美股牛股 | 医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%
医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%，获私募巨头溢价34%收购；CDNL升逾15%，高管近日增持320万美元股份>>
08-19 16:11
美股大行评级 | 潜在涨幅167.3%！HC Wainwright上调Tango Therapeutics目标价至68美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Tango Therapeutics"买入"评级，目标价从66美元升至68美元；康托·菲茨杰拉德：维持Duos Technologies Group"超配"评级，目标价从26美元升至27美元
08-19 08:37
CSL reports FY results
CSL press release (CSLLY): FY EPS of $6.20 Revenue of $15.8B. More on CSL CSL Limited (CSLLY) Q4 2026 Earnings Call Transcript CSL Limited 2026 Q4 - Results - Earnings Call Presentation Is CSL An Un...
08-19 03:52
Haemonetics Shares Hit New 52-Week High: What's Happening?
Shares of Haemonetics Corp (NYSE:HAE) are trading higher Tuesday afternoon following news of a significant commercial agreement. Haemonetics stock is challenging resistance. Why did HAE hit a new high? Key Terms and Implementation The Boston-based medical technology provider disclosed that it has ex...
08-19 01:12
Haemonetics rises after supply deal with CSL
Shares of Haemonetics (HAE) added ~7% in the premarket on Tuesday after the blood management solutions provider disclosed a supply agreement with Australian biopharma company CSL Limited (CSLLY) (CMXH...
08-18 18:51
Haemonetics To Supply CSL Plasma With Its NexSys PCS Devices With Persona PLUS Technology And Allow Purchases Of Related Disposables In The U.S.; Agreement Is Non-Exclusive And With No Minimum Purchase Commitments
Haemonetics anticipates CSL to transition a portion of its U.S. plasma collection centers to the Company’s devices and disposables, but the scope and timing of implementation have not yet been determined. Accordingly, the Company is not updating its previously issued fiscal 2027 guidance at this tim...
08-18 18:15
Haemonetics Lifts Outlook on Broad-Based Earnings Strength
Haemonetics (($HAE)) has held its Q1 earnings call. Read on for the main highli...
08-10 08:17
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
BTIG Maintains Buy on Haemonetics, Raises Price Target to $96
BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $84 to $96.
08-07 02:25
